Diseases Archives - Page 13 of 43 - Pharma Journalist

Prometic receives Rare Pediatric Disease Designation from FDA

Vanda Pharmaceutical’s HETLIOZ for symptoms of jet lag disorder

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075

Lyric finishes enrollment in Phase 2 PRROMOTE Study of LP101 in Enteral Feeding Intolerance

Glenmark Pharmaceuticals presents New Data on Ryaltris for treating SAR at AAAAI/WAO

Aimmune Therapeutics declares results of Phase 3 PALISADE Trial of AR101 for peanut allergy patients

MeiraGTx declares EMA’s extension of PRIME designation to A002

Christiana Stamoulis appointed president to Unum Therapeutics

FDA clears 1.0mm Coronary Balloon for Cardiovascular Systems